1. On the consensus nomenclature rules for radiopharmaceutical chemistry – Reconsideration of radiochemical conversion
- Author
-
Bernd Neumaier, Tobias L. Ross, Linjing Mu, Dmitrii Antuganov, Yearn Seong Choe, Urs O. Häfeli, Vladimir Shalgunov, Jacob Madsen, Roger Schibli, Allen F. Brooks, Wolfgang Wadsak, Nic Gillings, Guy Bormans, Raisa Krasikova, Andreas Bauman, Markus Piel, Simon M. Ametamey, Matthias M. Herth, Peter J. H. Scott, Michelle L. James, Klaus Kopka, Neil Vasdev, Mathias Berndt, Frank Rösch, Vasko Kramer, Brian M. Zeglis, University of Zurich, and Herth, Matthias M
- Subjects
Cancer Research ,Radiochemistry ,Nomenclature ,Radiochemical conversion ,Chemistry ,610 Medicine & health ,10181 Clinic for Nuclear Medicine ,Terminology ,030218 nuclear medicine & medical imaging ,Nuclear chemistry ,Radiochemical yield ,03 medical and health sciences ,0302 clinical medicine ,ddc:570 ,1313 Molecular Medicine ,030220 oncology & carcinogenesis ,Yield (chemistry) ,2741 Radiology, Nuclear Medicine and Imaging ,Molecular Medicine ,1306 Cancer Research ,Radiology, Nuclear Medicine and imaging ,Radiopharmaceutical sciences ,Consensus guidelines - Abstract
Radiochemical conversion is an important term to be included in the "Consensus nomenclature rules for radiopharmaceutical chemistry". Radiochemical conversion should be used to define reaction efficiency by measuring the transformation of components in a crude reaction mixture at a given time, whereas radiochemical yield is better suited to define the efficiency of an entire reaction process including, for example, separation, isolation, filtration, and formulation. (C) 2020 Elsevier Inc. All rights reserved.
- Published
- 2021